Analyst firms · Jefferies · NUVB
Jefferies NUVB price target and rating history
Nuvation Bio Inc. (NUVB) · Health Care
Jefferies rates Nuvation Bio Inc. (NUVB) Buy with a $10 price target, as of its latest action on Sep 30, 2025. It has published 3 rating actions on NUVB since January 2023, including 1 upgrade and 1 downgrade.
- Current rating
- Buy
- Price target
- $10
- Median target, all firms
- Too few
- Actions on NUVB
- 3
Jefferies price target on NUVB
Every Jefferies rating on NUVB
- Sep 30, 2025
- Mar 27, 2024
- Jan 6, 2023
How other firms rate NUVB
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Citigroup | Buy | $12 | Sep 30, 2026 |
| Cantor Fitzgerald | Overweight | Aug 21, 2026 | |
| Truist Securities | Buy | Nov 24, 2025 | |
| B. Riley Securities | Buy | $12 | Nov 19, 2025 |
Questions about Jefferies and NUVB
- What is Jefferies's price target for NUVB?
- Jefferies's latest stated price target for Nuvation Bio Inc. (NUVB) is $10, from its action on Sep 30, 2025.
- What is Jefferies's rating on NUVB?
- Jefferies rates NUVB Buy, a bullish rating, as of Sep 30, 2025.
- When did Jefferies last change its view on NUVB?
- On Sep 30, 2025, Jefferies starts coverage at Buy, price target $10.
More NUVB rating histories
All Jefferies ratingsNUVB news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.